B U von Specht

1.3k total citations
35 papers, 1.1k citations indexed

About

B U von Specht is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, B U von Specht has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Immunology. Recurrent topics in B U von Specht's work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Genetics and Biotechnology (6 papers) and Cystic Fibrosis Research Advances (5 papers). B U von Specht is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Bacterial Genetics and Biotechnology (6 papers) and Cystic Fibrosis Research Advances (5 papers). B U von Specht collaborates with scholars based in Germany, Austria and United States. B U von Specht's co-authors include H Domdey, Erfan Mansouri, Ulrich Baumann, Michael Duchêne, Dirk Bumann, Joachim Freihorst, Robert Hurwitz, Wolfram Metzger, Thomas F. Meyer and Toni Aebischer and has published in prestigious journals such as Neurology, American Journal of Respiratory and Critical Care Medicine and Gut.

In The Last Decade

B U von Specht

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by B U von Specht

Since Specialization

Citations

This map shows the geographic impact of B U von Specht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B U von Specht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B U von Specht more than expected).

Fields of papers citing papers by B U von Specht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B U von Specht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B U von Specht. The network helps show where B U von Specht may publish in the future.

Co-authorship network of co-authors of B U von Specht

This figure shows the co-authorship network connecting the top 25 collaborators of B U von Specht. A scholar is included among the top collaborators of B U von Specht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B U von Specht. B U von Specht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers 2009 ·Vaccine ·Dirk Bumann, (unknown), (unknown), (unknown), (unknown), J. Engelbert Gessner, B U von Specht, Ulrich Baumann	42
2	Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study 2007 ·Respiratory Research ·Ulrich Baumann, (unknown), (unknown), Joachim Freihorst, B U von Specht	36
3	Effect of Anti-OprF-OprI Immunoglobulin on APACHE II Score in a Porcine Two-Hit Model of Hemorrhagic Shock/Resuscitation and <i>Pseudomonas aeruginosa </i>Sepsis 2005 ·European Surgical Research ·Jörg Haberstroh, (unknown), B U von Specht	6
4	Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients 2004 ·Clinical & Experimental Metastasis ·(unknown), Joachim Großmann, (unknown), (unknown), (unknown), Annette Schmitt‐Graeff, B U von Specht	33
5	Mucosal vaccination with a recombinant OprF-I vaccine ofPseudomonas aeruginosain healthy volunteers: comparison of a systemic vs. a mucosal booster schedule 2003 ·FEMS Immunology & Medical Microbiology ·(unknown), Ulrich Baumann, (unknown), Josef Gabelsberger, Heinz Hahn, Joachim Freihorst, B U von Specht	36
6	Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers 2003 ·Vaccine ·Wolfram Metzger, Erfan Mansouri, (unknown), Susanne Diescher, (unknown), Robert Hurwitz, Dirk Bumann, Toni Aebischer, B U von Specht, Thomas F. Meyer	63
7	Recombinant OprF–OprI as a vaccine against Pseudomonas aeruginosa infections 2003 ·Vaccine ·Ulrich Baumann, Erfan Mansouri, B U von Specht	70
8	Chronic Porcine Two-Hit Model with Hemorrhagic Shock and <i>Pseudomonas aeruginosa</i> Sepsis 2002 ·European Surgical Research ·(unknown), (unknown), Alina Smorodchenko, (unknown), B U von Specht	9
9	Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers 2001 ·Vaccine ·(unknown), Erfan Mansouri, Joachim Freihorst, Burkhard Tümmler, Gottfried Köhler, H Domdey, Bernhard Knapp, (unknown), Erika Hundt, Josef Gabelsberger, B U von Specht	46
10	Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers 2001 ·Vaccine ·Dirk Bumann, Wolfram Metzger, Erfan Mansouri, (unknown), Meike Wendland, Robert Hurwitz, (unknown), Toni Aebischer, B U von Specht, Thomas F. Meyer	87
11	Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections 2000 ·Journal of Biotechnology ·B U von Specht, Josef Gabelsberger, Bernhard Knapp, Erika Hundt, (unknown), (unknown), (unknown), H Domdey	15
12	G-CSF during Escherichia coli versus Staphylococcus aureus Pneumonia in Rats Has Fundamentally Different and Opposite Effects 1999 ·American Journal of Respiratory and Critical Care Medicine ·Waheedullah Karzai, B U von Specht, Chantal Parent, Jörg Haberstroh, (unknown), Charles Natanson, Steven M. Banks, Peter Q. Eichacker	55
13	Expression and activity of mitogen activated protein kinases in human colorectal carcinoma 1999 ·Gut ·S. Eggstein, Martin Franke, Ingo Kutschka, (unknown), B U von Specht, G. Ruf, E. H. Farthmann	16
14	Effects of the Pringle Maneuver on Hemodynamics during Laparoscopic Liver Resection in the Pig 1996 ·European Surgical Research ·Jörg Haberstroh, (unknown), (unknown), (unknown), R. Salm, Ulrich Matern, (unknown), B U von Specht	26
15	Raf-1 kinase, epidermal growth factor receptors, and mutant ras proteins in colonic carcinomas 1996 ·Digestive Diseases and Sciences ·S. Eggstein, (unknown), Tobias Hirsch, Frank Baas, B U von Specht, E. H. Farthmann	8
16	Prevention of type I diabetes in the non-obese diabetic (NOD) mouse with 15-deoxyspergualin (15-DS) or 15-DS + cyclosporin A (CyA) 1995 ·Immunology Letters ·Jörg Haberstroh, Thomas Wilhelm, Jürgen Schulte‐Mönting, H. U. Schorlemmer, B U von Specht	3
17	Cultured gingival epithelium 1991 ·Journal of Cranio-Maxillofacial Surgery ·Günter Lauer, Jörg‐Elard Otten, B U von Specht, Wilfried Schilli	27
18	Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein OprI 1990 ·Infection ·(unknown), (unknown), B U von Specht, Michael Duchêne, H Domdey	3
19	Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli 1989 ·Journal of Bacteriology ·Michael Duchêne, (unknown), (unknown), B U von Specht, H Domdey	54
20	Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection 1987 ·Infection ·B U von Specht, (unknown), W. Brendel, W. Ehret	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact